<VariationArchive VariationID="219098" VariationName="NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn)"
    VariationType="single nucleotide variant" Accession="VCV000219098" Version="3"
    RecordType="classified" DateCreated="2016-12-02" DateLastUpdated="2020-06-27"
    NumberOfSubmissions="6" NumberOfSubmitters="5">
    <RecordStatus>current</RecordStatus>
    <Species>Homo sapiens</Species>
    <ClassifiedRecord>
        <SimpleAllele AlleleID="216787" VariationID="219098">
            <GeneList>
                <Gene Symbol="SF3B1" FullName="splicing factor 3b subunit 1" GeneID="23451"
                    HGNC_ID="HGNC:10768" Source="submitted" RelationshipType="within single gene">
                    <Location>
                        <CytogeneticLocation>2q33.1</CytogeneticLocation>
                        <SequenceLocation Assembly="GRCh38"
                            AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current"
                            Chr="2" Accession="NC_000002.12" start="197389784" stop="197435093"
                            display_start="197389784" display_stop="197435093" Strand="-" />
                        <SequenceLocation Assembly="GRCh37"
                            AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous"
                            Chr="2" Accession="NC_000002.11" start="198256697" stop="198299770"
                            display_start="198256697" display_stop="198299770" Strand="-" />
                    </Location>
                    <OMIM>605590</OMIM>
                </Gene>
            </GeneList>
            <Name>NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn)</Name>
            <CanonicalSPDI>NC_000002.12:197402634:C:A</CanonicalSPDI>
            <VariantType>single nucleotide variant</VariantType>
            <Location>
                <CytogeneticLocation>2q33.1</CytogeneticLocation>
                <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38"
                    forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12"
                    start="197402635" stop="197402635" display_start="197402635"
                    display_stop="197402635" variantLength="1" positionVCF="197402635"
                    referenceAlleleVCF="C" alternateAlleleVCF="A" />
                <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25"
                    AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="198267359"
                    stop="198267359" display_start="198267359" display_stop="198267359"
                    variantLength="1" positionVCF="198267359" referenceAlleleVCF="C"
                    alternateAlleleVCF="A" />
            </Location>
            <ProteinChange>K666N</ProteinChange>
            <HGVSlist>
                <HGVS Type="genomic">
                    <NucleotideExpression sequenceAccessionVersion="LRG_624"
                        sequenceAccession="LRG_624">
                        <Expression>LRG_624:g.37413G>T</Expression>
                    </NucleotideExpression>
                </HGVS>
                <HGVS Type="coding">
                    <NucleotideExpression sequenceAccessionVersion="LRG_624t2"
                        sequenceAccession="LRG_624t2">
                        <Expression>LRG_624t2:c.1998G>T</Expression>
                    </NucleotideExpression>
                    <ProteinExpression sequenceAccessionVersion="LRG_624p2"
                        sequenceAccession="LRG_624p2" change="p.Lys666Asn">
                        <Expression>LRG_624p2:p.Lys666Asn</Expression>
                    </ProteinExpression>
                </HGVS>
                <HGVS Assembly="GRCh37" Type="genomic, top-level">
                    <NucleotideExpression sequenceAccessionVersion="NC_000002.11"
                        sequenceAccession="NC_000002" sequenceVersion="11" change="g.198267359C>A"
                        Assembly="GRCh37">
                        <Expression>NC_000002.11:g.198267359C>A</Expression>
                    </NucleotideExpression>
                </HGVS>
                <HGVS Assembly="GRCh38" Type="genomic, top-level">
                    <NucleotideExpression sequenceAccessionVersion="NC_000002.12"
                        sequenceAccession="NC_000002" sequenceVersion="12" change="g.197402635C>A"
                        Assembly="GRCh38">
                        <Expression>NC_000002.12:g.197402635C>A</Expression>
                    </NucleotideExpression>
                </HGVS>
                <HGVS Type="genomic">
                    <NucleotideExpression sequenceAccessionVersion="NG_032903.2"
                        sequenceAccession="NG_032903" sequenceVersion="2" change="g.37413G>T">
                        <Expression>NG_032903.2:g.37413G>T</Expression>
                    </NucleotideExpression>
                </HGVS>
                <HGVS Type="coding">
                    <NucleotideExpression sequenceAccessionVersion="NM_012433.4"
                        sequenceAccession="NM_012433" sequenceVersion="4" change="c.1998G>T"
                        MANESelect="true">
                        <Expression>NM_012433.4:c.1998G>T</Expression>
                    </NucleotideExpression>
                    <ProteinExpression sequenceAccessionVersion="NP_036565.2"
                        sequenceAccession="NP_036565" sequenceVersion="2" change="p.Lys666Asn">
                        <Expression>NP_036565.2:p.Lys666Asn</Expression>
                    </ProteinExpression>
                    <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
                </HGVS>
            </HGVSlist>
            <XRefList>
                <XRef ID="CA280929" DB="ClinGen" />
                <XRef Type="rs" ID="377023736" DB="dbSNP" />
            </XRefList>
        </SimpleAllele>
        <RCVList>
            <RCVAccession
                Title="NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn) AND Breast adenocarcinoma"
                Accession="RCV000287776" Version="1">
                <ClassifiedConditionList TraitSetID="1088">
                    <ClassifiedCondition DB="MedGen" ID="C0858252">Breast adenocarcinoma</ClassifiedCondition>
                </ClassifiedConditionList>
                <RCVClassifications>
                    <SomaticClinicalImpact>
                        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                        <Description ClinicalImpactAssertionType="diagnostic"
                            ClinicalImpactClinicalSignificance="supports diagnosis"
                            SubmissionCount="1"
                            DateLastEvaluated="2016-06-14">Tier I - Strong</Description>
                    </SomaticClinicalImpact>
                    <OncogenicityClassification>
                        <ReviewStatus>reviewed by expert panel</ReviewStatus>
                        <Description DateLastEvaluated="2016-06-14" SubmissionCount="2">Oncogenic</Description>
                    </OncogenicityClassification>
                </RCVClassifications>
            </RCVAccession>
            <RCVAccession
                Title="NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn) AND Acute myeloid leukemia"
                Accession="RCV000303947" Version="1">
                <ClassifiedConditionList TraitSetID="6288">
                    <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
                </ClassifiedConditionList>
                <RCVClassifications>
                    <SomaticClinicalImpact>
                        <ReviewStatus>criteria provided, multiple submitters</ReviewStatus>
                        <Description ClinicalImpactAssertionType="therapeutic"
                            ClinicalImpactClinicalSignificance="sensitivity"
                            SubmissionCount="1" DateLastEvaluated="2016-06-14">Tier II - Potential</Description>
                        <Description ClinicalImpactAssertionType="therapeutic"
                            ClinicalImpactClinicalSignificance="resistance"
                            SubmissionCount="1" DateLastEvaluated="2016-06-14">Tier II - Potential</Description>
                    </SomaticClinicalImpact>
                </RCVClassifications>
            </RCVAccession>
            <RCVAccession
                Title="NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn) AND Carcinoma of pancreas"
                Accession="RCV000383398" Version="1">
                <ClassifiedConditionList TraitSetID="6482">
                    <ClassifiedCondition DB="MedGen" ID="C0235974">Carcinoma of pancreas</ClassifiedCondition>
                </ClassifiedConditionList>
                <RCVClassifications>
                    <SomaticClinicalImpact>
                        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                        <Description ClinicalImpactAssertionType="diagnostic"
                            ClinicalImpactClinicalSignificance="supports diagnosis"
                            SubmissionCount="1"
                            DateLastEvaluated="2016-06-14">Tier II - Potential</Description>
                    </SomaticClinicalImpact>
                </RCVClassifications>
            </RCVAccession>
        </RCVList>
        <Classifications>
            <SomaticClinicalImpact DateLastEvaluated="2016-06-14" DateCreated="2016-12-02"
                MostRecentSubmission="2019-03-31" NumberOfSubmitters="4" NumberOfSubmissions="3">
                <ReviewStatus>criteria provided, multiple submitters</ReviewStatus>
                <Description>Tier I - Strong</Description>
                <ConditionList>
                    <TraitSet ID="1088" Type="Disease" ContributesToAggregateClassification="true">
                        <Trait ID="18584" Type="Disease">
                            <Name>
                                <ElementValue Type="Alternate">Breast cancer, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Breast adenocarcinoma, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Preferred">Breast adenocarcinoma</ElementValue>
                                <XRef ID="MONDO:0004988" DB="MONDO" />
                            </Name>
                            <XRef ID="C0858252" DB="MedGen" />
                            <XRef ID="MONDO:0004988" DB="MONDO" />
                        </Trait>
                    </TraitSet>
                    <TraitSet ID="6288" Type="Disease" ContributesToAggregateClassification="false" LowerLevelOfEvidence="true">
                        <Trait ID="15736" Type="Disease">
                            <Name>
                                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                                <XRef ID="MONDO:0018874" DB="MONDO" />
                                <XRef ID="519" DB="Orphanet" />
                                <XRef ID="17788007" DB="SNOMED CT" />
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">AML adult</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
                            </Name>
                            <Symbol>
                                <ElementValue Type="Preferred">AML</ElementValue>
                                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                                <XRef Type="MIM" ID="601626" DB="OMIM" />
                            </Symbol>
                            <AttributeSet>
                                <Attribute Type="public definition">CEBPA-associated familial acute
                                    myeloid leukemia (AML) is defined as the presence of a
                                    heterozygous germline CEBPA pathogenic variant in an individual
                                    with AML and/or family in which more than one individual has
                                    AML. In contrast, sporadic CEBPA-associated AML is defined as
                                    AML in which a CEBPA pathogenic variant(s) is identified in
                                    leukemic cells but not in the non-leukemic cells. In the
                                    majority of individuals, the age of onset of familial AML
                                    appears to be earlier than sporadic AML; disease onset has been
                                    reported in persons as young as age 1.8 years and up to age 50
                                    years. The prognosis of CEBPA-associated familial AML appears to
                                    be favorable compared with sporadic CEBPA-associated AML.
                                    Individuals with CEBPA-associated familial AML who have been
                                    cured of their initial disease may be at greater risk of
                                    developing additional independent leukemic episodes, in addition
                                    to the risk of relapse from preexisting clones.</Attribute>
                                <XRef ID="NBK47457" DB="GeneReviews" />
                            </AttributeSet>
                            <AttributeSet>
                                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
                            </AttributeSet>
                            <Citation Type="review" Abbrev="GeneReviews">
                                <ID Source="PubMed">20963938</ID>
                                <ID Source="BookShelf">NBK47457</ID>
                            </Citation>
                            <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                                <ID Source="PubMed">22138009</ID>
                            </Citation>
                            <Citation Type="practice guideline" Abbrev="ESMO, 2013">
                                <ID Source="PubMed">23970018</ID>
                            </Citation>
                            <Citation Type="review" Abbrev="GeneReviews">
                                <ID Source="PubMed">33226740</ID>
                                <ID Source="BookShelf">NBK564234</ID>
                            </Citation>
                            <Citation Type="practice guideline" Abbrev="ESMO, 2020">
                                <ID Source="PubMed">32171751</ID>
                            </Citation>
                            <XRef ID="519" DB="Orphanet" />
                            <XRef ID="C0023467" DB="MedGen" />
                            <XRef ID="D015470" DB="MeSH" />
                            <XRef ID="MONDO:0018874" DB="MONDO" />
                            <XRef Type="MIM" ID="601626" DB="OMIM" />
                            <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
                            <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
                            <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
                            <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
                            <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
                            <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
                        </Trait>
                    </TraitSet>
                    <TraitSet ID="6482" Type="Disease" ContributesToAggregateClassification="false" LowerLevelOfEvidence="true">
                        <Trait ID="5725" Type="Disease">
                            <Name>
                                <ElementValue Type="Alternate">PANCREATIC ACINAR CARCINOMA</ElementValue>
                                <XRef Type="MIM" ID="260350" DB="OMIM" />
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">PANCREATIC CARCINOMA</ElementValue>
                                <XRef Type="MIM" ID="260350" DB="OMIM" />
                            </Name>
                            <Name>
                                <ElementValue Type="Preferred">Carcinoma of pancreas</ElementValue>
                                <XRef ID="372142002" DB="SNOMED CT" />
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Pancreatic cancer, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Pancreatic carcinoma, somatic</ElementValue>
                            </Name>
                            <AttributeSet>
                                <Attribute Type="disease mechanism" integerValue="273">loss of
                                    function</Attribute>
                                <XRef ID="GTR000012368" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000509790" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000514885" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520871" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000523331" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000523332" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000528055" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000569881" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000569885" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000592354" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000593406" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000528054" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000552440" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000592353" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000512726" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520866" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520867" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000523334" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000593404" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000593405" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                                <XRef ID="GTR000525919" DB="Genetic Testing Registry (GTR)" />
                            </AttributeSet>
                            <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                                <URL>
                                    https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                                <CitationText>Technology Assessment on Genetic Testing or Molecular
                                    Pathology Testing of Cancers with Unknown Primary Site to
                                    Determine Origin (ARCHIVED)</CitationText>
                            </Citation>
                            <Citation Type="general" Abbrev="ASCO, 2006">
                                <ID Source="PubMed">17060676</ID>
                            </Citation>
                            <Citation Type="general" Abbrev="ASCO, 2014">
                                <ID Source="PubMed">24493721</ID>
                            </Citation>
                            <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                                <ID Source="PubMed">25394175</ID>
                            </Citation>
                            <XRef ID="1333" DB="Orphanet" />
                            <XRef ID="217074" DB="Orphanet" />
                            <XRef ID="C0235974" DB="MedGen" />
                            <XRef ID="C562463" DB="MeSH" />
                            <XRef ID="MONDO:0005192" DB="MONDO" />
                            <XRef Type="MIM" ID="260350" DB="OMIM" />
                        </Trait>
                    </TraitSet>
                </ConditionList>
            </SomaticClinicalImpact>
            <OncogenicityClassification DateLastEvaluated="2016-06-14" DateCreated="2016-12-02"
                MostRecentSubmission="2019-03-31" NumberOfSubmitters="2" NumberOfSubmissions="2">
                <ReviewStatus>reviewed by expert panel</ReviewStatus>
                <Description>Oncogenic</Description>
                <ConditionList>
                    <TraitSet ID="1088" Type="Disease" ContributesToAggregateClassification="true">
                        <Trait ID="18584" Type="Disease">
                            <Name>
                                <ElementValue Type="Alternate">Breast cancer, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Alternate">Breast adenocarcinoma, somatic</ElementValue>
                            </Name>
                            <Name>
                                <ElementValue Type="Preferred">Breast adenocarcinoma</ElementValue>
                                <XRef ID="MONDO:0004988" DB="MONDO" />
                            </Name>
                            <XRef ID="C0858252" DB="MedGen" />
                            <XRef ID="MONDO:0004988" DB="MONDO" />
                        </Trait>
                    </TraitSet>
                </ConditionList>
            </OncogenicityClassification>
        </Classifications>
        <ClinicalAssertionList>
            <ClinicalAssertion ID="717591" DateCreated="2016-12-02" DateLastUpdated="2019-03-31"
                SubmissionDate="2016-10-18">
                <ClinVarSubmissionID localKey="562510-3" submittedAssembly="GRCh37" />
                <ClinVarAccession Accession="SCV000404070" Type="SCV" Version="2"
                    SubmitterName="Database of Curated Mutations (DoCM)" OrgID="505871"
                    OrganizationCategory="resource" OrgAbbreviation="DoCM" />
                <RecordStatus>current</RecordStatus>
                <Classification DateLastEvaluated="2016-06-14">
                    <ReviewStatus>reviewed by expert panel</ReviewStatus>
                    <OncogenicityClassification>Oncogenic</OncogenicityClassification>
                </Classification>
                <Assertion>variation to disease</Assertion>
                <AttributeSet>
                    <Attribute Type="AssertionMethod">Oncogenicity SOP (ClinGen, CGC, VICC guidelines) 2022</Attribute>
                    <Citation>
                        <ID Source="PubMed">35101336</ID>
                    </Citation>
                </AttributeSet>
                <ObservedInList>
                    <ObservedIn>
                        <Sample>
                            <Origin>somatic</Origin>
                            <SomaticVariantInNormalTissue>present</SomaticVariantInNormalTissue>
                            <SomaticVariantAlleleFraction>25%</SomaticVariantAlleleFraction>
                            <Species TaxonomyId="9606">human</Species>
                            <AffectedStatus>unknown</AffectedStatus>
                        </Sample>
                        <Method>
                            <MethodType>clinical testing</MethodType>
                        </Method>
                        <ObservedData>
                            <Attribute Type="Description">not provided</Attribute>
                        </ObservedData>
                    </ObservedIn>
                </ObservedInList>
                <SimpleAllele>
                    <VariantType>Variation</VariantType>
                    <Location>
                        <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="A"
                            referenceAllele="C" start="198267359" stop="198267359" variantLength="1" />
                    </Location>
                </SimpleAllele>
                <TraitSet Type="Disease">
                    <Trait Type="Disease">
                        <Name>
                            <ElementValue Type="Preferred">BREAST CANCER, SOMATIC</ElementValue>
                        </Name>
                    </Trait>
                </TraitSet>
                <SubmissionNameList>
                    <SubmissionName>ICSL_2016Q4</SubmissionName>
                </SubmissionNameList>
            </ClinicalAssertion>
            <ClinicalAssertion ID="717597" DateCreated="2016-12-02" DateLastUpdated="2019-03-31"
                SubmissionDate="2016-10-18">
                <ClinVarSubmissionID localKey="800692-1" submittedAssembly="GRCh37" />
                <ClinVarAccession Accession="SCV000404076" Type="SCV" Version="2"
                    SubmitterName="ClinVar" OrgID="500139"
                    OrganizationCategory="other" />
                <RecordStatus>current</RecordStatus>
                <Classification DateLastEvaluated="2016-06-14">
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <SomaticClinicalImpact ClinicalImpactAssertionType="diagnostic"
                        ClinicalImpactClinicalSignificance="supports diagnosis">Tier II - Potential</SomaticClinicalImpact>
                </Classification>
                <Assertion>variation to disease</Assertion>
                <AttributeSet>
                    <Attribute Type="AssertionMethod">AMP Guidelines, 2017</Attribute>
                    <Citation>
                        <ID Source="PubMed">27993330</ID>
                    </Citation>
                </AttributeSet>
                <ObservedInList>
                    <ObservedIn>
                        <Sample>
                            <Origin>somatic</Origin>
                            <SomaticVariantInNormalTissue>present</SomaticVariantInNormalTissue>
                            <SomaticVariantAlleleFraction>15%</SomaticVariantAlleleFraction>
                            <Species TaxonomyId="9606">human</Species>
                            <AffectedStatus>unknown</AffectedStatus>
                        </Sample>
                        <Method>
                            <MethodType>clinical testing</MethodType>
                        </Method>
                        <ObservedData>
                            <Attribute Type="Description">not provided</Attribute>
                        </ObservedData>
                    </ObservedIn>
                </ObservedInList>
                <SimpleAllele>
                    <VariantType>Variation</VariantType>
                    <Location>
                        <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="A"
                            referenceAllele="C" start="198267359" stop="198267359" variantLength="1" />
                    </Location>
                </SimpleAllele>
                <TraitSet Type="Disease">
                    <Trait Type="Disease">
                        <Name>
                            <ElementValue Type="Preferred">Pancreatic Cancer</ElementValue>
                        </Name>
                    </Trait>
                </TraitSet>
                <SubmissionNameList>
                    <SubmissionName>ICSL_2017Q1</SubmissionName>
                </SubmissionNameList>
            </ClinicalAssertion>
            <ClinicalAssertion ID="717596" DateCreated="2016-12-02" DateLastUpdated="2019-03-31"
                SubmissionDate="2016-10-18">
                <ClinVarSubmissionID localKey="800692-3"
                    submittedAssembly="GRCh37" />
                <ClinVarAccession Accession="SCV000404075" Type="SCV" Version="2"
                    SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
                <RecordStatus>current</RecordStatus>
                <Classification DateLastEvaluated="2016-06-14">
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <SomaticClinicalImpact ClinicalImpactAssertionType="diagnostic"
                        ClinicalImpactClinicalSignificance="supports diagnosis">Tier I - Strong</SomaticClinicalImpact>
                </Classification>
                <Assertion>variation to disease</Assertion>
                <AttributeSet>
                    <Attribute Type="AssertionMethod">AMP Guidelines, 2017</Attribute>
                    <Citation>
                        <ID Source="PubMed">27993330</ID>
                    </Citation>
                </AttributeSet>
                <ObservedInList>
                    <ObservedIn>
                        <Sample>
                            <Origin>somatic</Origin>
                            <SomaticVariantInNormalTissue>present</SomaticVariantInNormalTissue>
                            <SomaticVariantAlleleFraction>15%</SomaticVariantAlleleFraction>
                            <Species TaxonomyId="9606">human</Species>
                            <AffectedStatus>unknown</AffectedStatus>
                        </Sample>
                        <Method>
                            <MethodType>clinical testing</MethodType>
                        </Method>
                        <ObservedData>
                            <Attribute Type="Description">not provided</Attribute>
                        </ObservedData>
                    </ObservedIn>
                </ObservedInList>
                <SimpleAllele>
                    <VariantType>Variation</VariantType>
                    <Location>
                        <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="A"
                            referenceAllele="C" start="198267359" stop="198267359" variantLength="1" />
                    </Location>
                </SimpleAllele>
                <TraitSet Type="Disease">
                    <Trait Type="Disease">
                        <Name>
                            <ElementValue Type="Preferred">BREAST CANCER, SOMATIC</ElementValue>
                        </Name>
                    </Trait>
                </TraitSet>
                <SubmissionNameList>
                    <SubmissionName>ICSL_2017Q2</SubmissionName>
                </SubmissionNameList>
            </ClinicalAssertion>
            <ClinicalAssertion ID="717590" DateCreated="2016-12-02" DateLastUpdated="2019-03-31"
                SubmissionDate="2016-10-18">
                <ClinVarSubmissionID localKey="562510-1" submittedAssembly="GRCh37" />
                <ClinVarAccession Accession="SCV000404069" Type="SCV" Version="2"
                    SubmitterName="COSMIC: Catalogue of somatic mutations in cancer" OrgID="505269"
                    OrganizationCategory="resource" />
                <RecordStatus>current</RecordStatus>
                <Classification DateLastEvaluated="2016-06-14">
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <SomaticClinicalImpact ClinicalImpactAssertionType="therapeutic"
                        ClinicalImpactClinicalSignificance="sensitivity"
                        DrugForTherapeuticAssertion="Enzalutamide">Tier II - Potential</SomaticClinicalImpact>
                </Classification>
                <Assertion>variation to disease</Assertion>
                <AttributeSet>
                    <Attribute Type="AssertionMethod">AMP Guidelines, 2017</Attribute>
                    <Citation>
                        <ID Source="PubMed">27993330</ID>
                    </Citation>
                </AttributeSet>
                <ObservedInList>
                    <ObservedIn>
                        <Sample>
                            <Origin>somatic</Origin>
                            <SomaticVariantInNormalTissue>present</SomaticVariantInNormalTissue>
                            <SomaticVariantAlleleFraction>25%</SomaticVariantAlleleFraction>
                            <Species TaxonomyId="9606">human</Species>
                            <AffectedStatus>unknown</AffectedStatus>
                        </Sample>
                        <Method>
                            <MethodType>clinical testing</MethodType>
                        </Method>
                        <ObservedData>
                            <Attribute Type="Description">not provided</Attribute>
                        </ObservedData>
                    </ObservedIn>
                </ObservedInList>
                <SimpleAllele>
                    <VariantType>Variation</VariantType>
                    <Location>
                        <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="A"
                            referenceAllele="C" start="198267359" stop="198267359" variantLength="1" />
                    </Location>
                </SimpleAllele>
                <TraitSet Type="Disease">
                    <Trait Type="Disease">
                        <XRef DB="MeSH" ID="D015470" />
                    </Trait>
                </TraitSet>
                <SubmissionNameList>
                    <SubmissionName>DCM_2016Q4</SubmissionName>
                </SubmissionNameList>
            </ClinicalAssertion>
            <ClinicalAssertion ID="717595" DateCreated="2016-12-02" DateLastUpdated="2019-03-31"
                SubmissionDate="2016-10-18">
                <ClinVarSubmissionID localKey="800692-2" submittedAssembly="GRCh37" />
                <ClinVarAccession Accession="SCV000404074" Type="SCV" Version="2"
                    SubmitterName="ClinVar" OrgID="500139"
                    OrganizationCategory="other" />
                <RecordStatus>current</RecordStatus>
                <Classification DateLastEvaluated="2016-06-14">
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <SomaticClinicalImpact ClinicalImpactAssertionType="therapeutic"
                        ClinicalImpactClinicalSignificance="resistance"
                        DrugForTherapeuticAssertion="SpliceostatinA">Tier II - Potential</SomaticClinicalImpact>
                </Classification>
                <Assertion>variation to disease</Assertion>
                <AttributeSet>
                    <Attribute Type="AssertionMethod">AMP Guidelines, 2017</Attribute>
                    <Citation>
                        <ID Source="PubMed">27993330</ID>
                    </Citation>
                </AttributeSet>
                <ObservedInList>
                    <ObservedIn>
                        <Sample>
                            <Origin>somatic</Origin>
                            <SomaticVariantInNormalTissue>present</SomaticVariantInNormalTissue>
                            <SomaticVariantAlleleFraction>10%</SomaticVariantAlleleFraction>
                            <Species TaxonomyId="9606">human</Species>
                            <AffectedStatus>yes</AffectedStatus>
                        </Sample>
                        <Method>
                            <MethodType>clinical testing</MethodType>
                        </Method>
                        <ObservedData>
                            <Attribute Type="Description">not provided</Attribute>
                        </ObservedData>
                    </ObservedIn>
                </ObservedInList>
                <SimpleAllele>
                    <VariantType>Variation</VariantType>
                    <Location>
                        <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="A"
                            referenceAllele="C" start="198267359" stop="198267359" variantLength="1" />
                    </Location>
                </SimpleAllele>
                <TraitSet Type="Disease">
                    <Trait Type="Disease">
                        <XRef DB="MeSH" ID="D015470" />
                    </Trait>
                </TraitSet>
                <SubmissionNameList>
                    <SubmissionName>ICMLK_2016Q4</SubmissionName>
                </SubmissionNameList>
            </ClinicalAssertion>
            <ClinicalAssertion ID="717589" DateCreated="2016-12-02" DateLastUpdated="2019-03-31"
                SubmissionDate="2016-10-18">
                <ClinVarSubmissionID localKey="562510-3"
                    submittedAssembly="GRCh37" />
                <ClinVarAccession Accession="SCV000404068" Type="SCV" Version="2"
                    SubmitterName="CIViC knowledgebase" OrgID="506594"
                    OrganizationCategory="resource" />
                <RecordStatus>current</RecordStatus>
                <Classification DateLastEvaluated="2016-06-14">
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <OncogenicityClassification>Likely oncogenic</OncogenicityClassification>
                </Classification>
                <Assertion>variation to disease</Assertion>
                <AttributeSet>
                    <Attribute Type="AssertionMethod">Oncogenicity SOP (ClinGen, CGC, VICC guidelines) 2022</Attribute>
                    <Citation>
                        <ID Source="PubMed">35101336</ID>
                    </Citation>
                </AttributeSet>
                <ObservedInList>
                    <ObservedIn>
                        <Sample>
                            <Origin>somatic</Origin>
                            <SomaticVariantInNormalTissue>present</SomaticVariantInNormalTissue>
                            <SomaticVariantAlleleFraction>15%</SomaticVariantAlleleFraction>
                            <Species TaxonomyId="9606">human</Species>
                            <AffectedStatus>unknown</AffectedStatus>
                        </Sample>
                        <Method>
                            <MethodType>clinical testing</MethodType>
                        </Method>
                        <ObservedData>
                            <Attribute Type="Description">not provided</Attribute>
                        </ObservedData>
                    </ObservedIn>
                </ObservedInList>
                <SimpleAllele>
                    <VariantType>Variation</VariantType>
                    <Location>
                        <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="A"
                            referenceAllele="C" start="198267359" stop="198267359" variantLength="1" />
                    </Location>
                </SimpleAllele>
                <TraitSet Type="Disease">
                    <Trait Type="Disease">
                        <Name>
                            <ElementValue Type="Preferred">BREAST CANCER, SOMATIC</ElementValue>
                        </Name>
                    </Trait>
                </TraitSet>
                <SubmissionNameList>
                    <SubmissionName>ILFI_2016Q4</SubmissionName>
                </SubmissionNameList>
            </ClinicalAssertion>
        </ClinicalAssertionList>
        <TraitMappingList>
            <TraitMapping ClinicalAssertionID="717596" TraitType="Disease" MappingType="Name"
                MappingValue="BREAST CANCER, SOMATIC" MappingRef="Preferred">
                <MedGen CUI="C0858252" Name="Breast adenocarcinoma" />
            </TraitMapping>
            <TraitMapping ClinicalAssertionID="717589" TraitType="Disease" MappingType="Name"
                MappingValue="BREAST CANCER, SOMATIC" MappingRef="Preferred">
                <MedGen CUI="C0858252" Name="Breast adenocarcinoma" />
            </TraitMapping>
            <TraitMapping ClinicalAssertionID="717591" TraitType="Disease" MappingType="Name"
                MappingValue="BREAST CANCER, SOMATIC" MappingRef="Preferred">
                <MedGen CUI="C0858252" Name="Breast adenocarcinoma" />
            </TraitMapping>
            <TraitMapping ClinicalAssertionID="717590" TraitType="Disease" MappingType="XRef"
                MappingValue="D015470" MappingRef="MeSH">
                <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
            </TraitMapping>
            <TraitMapping ClinicalAssertionID="717595" TraitType="Disease" MappingType="XRef"
                MappingValue="D015470" MappingRef="MeSH">
                <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
            </TraitMapping>
            <TraitMapping ClinicalAssertionID="717597" TraitType="Disease" MappingType="Name"
                MappingValue="Pancreatic Cancer" MappingRef="Preferred">
                <MedGen CUI="C0346647" Name="Cancer of the pancreas" />
            </TraitMapping>
        </TraitMappingList>
    </ClassifiedRecord>
</VariationArchive>